PLUS THERAPEUTICS, INC.·4

Jan 2, 4:30 PM ET

Sims Andrew John Hugh MacIntyre 4

4 · PLUS THERAPEUTICS, INC. · Filed Jan 2, 2026

Insider Transaction Report

Form 4
Period: 2026-01-01
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-01+38,323106,461 total
  • Exercise/Conversion

    Restricted Stock Units

    2026-01-0138,323383,232 total
    Exercise: $0.00Common Stock (38,323 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
  • [F2]Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4